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1  | COMMENTARY
Antimicrobial resistance (AMR) is a relevant problem for human 
health as recognized by several independent agencies, governments, 
and international organizations, including the WHO and the UN 
among others (Govindaraj Vaithinathan & Vanitha, 2018). The prob‐
lem is not restricted to human‐linked habitats, since different works 
have shown that other ecosystems, including animals, soil and water 
bodies contribute to the origin, spread and maintenance of AMR, 
hence being a One Health problem (Berendonk et al., 2015). Besides, 
AMR bacteria (AMRB) can expand through different geographical 
areas, which constitutes a Global Health problem (Hernando‐Amado, 
Coque, Baquero, & Martinez, 2019). Understanding the elements in‐
volved in the emergence of resistance as well as the ways of coun‐
teracting such resistance, requires then integrated approaches 
where the ecological and evolutionary aspects of antimicrobial 
resistance are taken into consideration (Baquero, Alvarez‐Ortega, 
& Martinez, 2009). In the current special issue on Antimicrobial 
Resistance, MicrobiologyOpen presents a set of articles covering 
different areas of AMR, from the study of reservoirs and vectors for 
its dissemination to the analysis of novel antimicrobial compounds 
with potential therapeutic use.
Besides being a relevant health problem, AMRB and AMR genes 
(AMRGs) released from human‐linked reservoirs constitute nowa‐
days a pollution problem. Thus, knowing where and how they can 
be inactivated is a subject of interest (Martinez, 2012). This issue 
has been addressed by analyzing the levels and diversity of AMRGs 
in sandy beach environments compared with mangroves of South 
China, these last receiving sewage and aquaculture wastewater 
from coastal regions (Zhao et al., 2019). Notably, the authors found 
that the total abundance of AMRGs is lower in mangrove sediments. 
Despite the authors state that the properties of the sediment and 
the presence of mobile genetic elements are the most relevant ele‐
ments in shaping the AMRGs, it is relevant to state that, as described 
by others (Forsberg et al., 2014), most analyzed genes are intrinsic 
AMRGs, indicating that the phylogenetic composition of the com‐
munity should also be relevant. One important element for under‐
standing the spread of AMR is the delimitation of the transmission 
routes. Wild birds, particularly migratory ones, can contribute to 
such dissemination, being a potential vector for AMR spread among 
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Abstract
Infectious diseases still stand as a major cause of morbidity and mortality, and this 
problem can be worsened with the current antimicrobial resistance crisis. To tackle 
this crisis more studies analyzing the causes, routes, and reservoirs where antimicro‐
bial resistance can emerge and expand, together with new antimicrobials and strate‐
gies for fighting antimicrobial resistance are needed. In the current special issue of 
MicrobiologyOpen, a set of articles dealing with the multiple faces of antimicrobial 
resistance are presented. These articles provide new information for understanding 
and addressing this problem.
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geographically distinct areas (Bonnedahl & Jarhult, 2014). The 
analysis of fecal samples from short‐ and long‐distance migratory 
wild birds in Switzerland (Zurfluh et al., 2019) showed that 5.8% of 
the birds contained AMR Escherichia coli and several of them har‐
bored clinically‐relevant extended‐spectrum beta‐lactamases as 
CTX‐M‐15, CTX‐M‐55, or CTX‐M‐65. Since several of these birds 
are present in both, urbanized and natural environments, they could 
potentially spread AMRBs within and between these environments.
One of the challenges to face AMR is the lack of quantitative mod‐
els for analyzing its dissemination. A probabilistic model to estimate 
cross‐contamination and recontamination by methicillin‐resistant 
Staphylococcus aureus in retail meat via hands and cookware during 
a household barbecue is presented in (Plaza‐Rodriguez, Kaesbohrer, 
& Tenhagen, 2019). According to this model, the probability of one 
ARMB to be transferred from the contaminated raw chicken meat 
to the final serving is low. The application of this model to other 
potential transmission routes may help in quantifying the relevance 
of each one of them. These models can be fueled by the genomic 
analysis of recent opportunistic pathogens, particularly those with 
an environmental origin that can spread through human‐linked and 
environmental reservoirs. This is the case of Elizabethkingia anoph‐
elis, an emerging and frequently misdiagnosed opportunistic patho‐
gen, whose AMR spectra and pathogenesis mechanisms are still 
unclear. The genome of a clinical isolate presenting resistance to 20 
antibiotics was sequenced, and genes encoding different beta‐lact‐
amases and efflux pumps, as well as several potential virulence fac‐
tors, were found (Wang et al., 2019). The comparison of three clinical 
and two environmental E. anopheles strains showed that they pres‐
ent similar AMRGs and virulence determinants, further highlighting 
the role that natural ecosystems may have in the spread of AMRBs 
(Martinez, 2008). Even once the genomes of a pathogenic species 
have been sequenced, and the molecular basis for AMR predicted, 
fast, reliable, and cheap methods for their detection is needed. One 
example of this situation is the Aeromonas genus, in which the phe‐
notypic identification of species causing human infections is not 
always easy. Proteomic identification by MALDI‐TOF MS, linked to 
classical susceptibility tests, emerges as a valuable tool, in terms of 
time‐efficiency and low‐costs, for solving this issue (Elbehiry et al., 
2019). It is important to notice that fast detection and molecular epi‐
demiological surveys of AMR require previous knowledge of the mo‐
lecular basis of resistance (McArthur & Wright, 2015); and predictive 
approaches are of utmost relevance for this purpose (Martinez, 
Baquero, & Andersson, 2007). Two articles in this special issue make 
use of these methods to predict the emergence of resistance to 
two antimicrobials produced by lactic bacteria: nisin (Arii, Kawada‐
Matsuo, Oogai, Noguchi, & Komatsuzawa, 2019), an antibacterial 
peptide used as a food preservative, and the bacteriocin plantaricin 
EF (Heeney, Yarov‐Yarovoy, & Marco, 2019). Mutations that lead to 
plantaricin resistance are located in the corC gene, which encodes a 
putative membrane‐bound magnesium/cobalt efflux protein, which 
is supposed to be the bacteriocin target. Thus, the mechanism of ac‐
tion of plantaricin EF could be linked to modifications in the bacterial 
metal homeostasis. S. aureus, on its hand, acquires resistance to nisin 
as a consequence of the selection of mutations in the two‐compo‐
nent system BraRS, which in turn leads to the increased expression 
of the VraDE efflux pump, also known to be involved in daptomycin 
and gallidermin resistance (Popella et al., 2016). These results high‐
light the fact that the acquisition of resistance to one antibiotic can 
modify the susceptibility to others, either reducing (cross‐resistance) 
or increasing (collateral sensitivity) bacterial susceptibility to them. 
While the analysis of cross‐resistance phenotypes gives clues for 
avoiding the use of some specific antibiotics when bacteria have ac‐
quired resistance to another one, the analysis of the collateral sensi‐
tivity networks can help to develop combined or cyclic therapeutic 
regimes (Podnecky et al., 2018; Sanz‐Garcia, Hernando‐Amado, & 
Martinez, 2018). Indeed, Pseudomonas aeruginosa mutants selected 
in the presence of carbapenems presented decreased susceptibility 
to doripenem, meropenem, and imipenem, while their susceptibility 
to aminoglycosides, fluoroquinolones, and noncarbapenem β‐lact‐
ams was higher than that of the parental clinical isolate from which 
these mutants derive (Harrison, Fowler, Abdalhamid, Selmecki, & 
Hanson, 2019). While alterations in the porin OprD, the entrance 
channel for carbapenems, were responsible for the increased resis‐
tance to these antibiotics, modifications in the lipopolysaccharide 
were likely the cause of aminoglycoside hypersensitivity. These evo‐
lutionary constraints imposed by collateral sensitivity could be ex‐
ploited in the clinics to the rational design of treatments.
Most studies on AMR are based on the analysis of resistance to 
industrially produced antimicrobials used in therapy or for prophy‐
lactic purposes. Nevertheless, it is important to recall that the in‐
fected organisms can produce a set of antimicrobial compounds and 
knowing the bacterial mechanisms of resistance to such compounds 
is of utmost relevance for understanding infection. As shown by 
Desloges et al., (2019), the capacity of uropathogenic E. coli to resist 
being killed by antimicrobial peptides during urinary tract infections 
(UTIs) is mediated by the protease OmpT. Noteworthy, the presence 
of another ompT‐like gene (arlC) causes higher clinical severity in the 
UTIs. Therefore, the presence of this second AMRG should be taken 
into consideration for diagnostic and prognostic purposes in E. coli 
urinary infections.
One of the main causes of the increasing problem of AMR is 
the lack of novel antimicrobials or therapeutic approaches (Bush 
et al., 2011), a matter that is also explored in the current special 
issue of MicrobiologyOpen. To that purpose, different strategies 
could be implemented. The search of naturally‐produced com‐
pounds is exemplified by the article of Horta et al., (Horta et al., 
2019), where the biodiversity of bacteria associated with the red 
seaweed Asparagopsis armata, together with the production of 
antimicrobial compounds by these microorganisms, is analyzed. 
Two of the investigated isolates produce potent anti–Gram‐posi‐
tive antimicrobials, suggesting that the microbiota associated with 
A. armata can be a source of compounds with pharmacological in‐
terest. Genome mining of antimicrobial producers may also help in 
developing novel antimicrobials (Desloges et al., 2019). Using this 
approach, Nakaew et al., (Nakaew, Lumyong, Sloan, & Sungthong, 
2019) showed that an antibiotic‐producing Streptomyces sp. isolate 
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encodes in its genome, not only biosynthetic pathways of already 
known antimicrobials but also pathways predicted to be involved 
in the biosynthesis of novel antibiotics, which, as above stated, 
are urgently needed. Most antibiotics currently in use are of natu‐
ral origin or derived from natural antimicrobials. However, purely 
synthetic antimicrobials as quinolones can also effectively inhibit 
bacterial pathogen growth. A synthetic approach was followed 
by Serafim et al., (Serafim et al., 2019) for synthesizing new 1,3‐
bis(arloxy)propan‐2‐amines with biological activity against Gram‐
positive pathogens such as Streptococcus pyogenes, Enterococcus 
faecalis, and S. aureus. By using docking approaches, the authors 
suggest that their compounds might bind to the cell division pro‐
tein FtsZ. Although these predictions are far away to be con‐
firmed, anti‐FtsZ antimicrobials should constitute a novel group of 
antibiotics with clear clinical value (Panda et al., 2016).
It is relevant to remind that the use of antimicrobials is not re‐
stricted to the treatment of human infections. They are also used 
in animal and crop production. Consequently, the use of new anti‐
infective approaches for avoiding infections associated with these 
activities would reduce the global antimicrobial load, which will 
have a positive effect in reducing the AMR burden. One of these 
approaches can be combination therapy as described by Procopio 
et al (Procopio et al., 2019). In their study, the authors showed that 
the lectin CasuL is a bacteriostatic and antibiofilm agent against 
some Staphylococcal isolates obtained from animals with mastitis. 
Besides, it presents a synergistic activity when used in combination 
with antibiotics, supporting the need for conducting new studies to 
determine the feasibility of this approach in the treatment of caprine 
and bovine mastitis. A classical way for avoiding infections in crops is 
the development of transgenic plants with anti‐infective properties. 
Khademi et al., (Khademi, Nazarian‐Firouzabadi, Ismaili, & Shirzadian 
Khorramabad, 2019) developed transgenic tobacco plants which 
were able to produce dermaseptin B1, an antimicrobial peptide pro‐
duced by Phyllomedusa bicolor. The purified recombinant peptide 
presented a strong antimicrobial activity, suggesting it can be useful 
as a novel compound for treating plants infections. Also, the results 
suggest that transgenic plants expressing dermaseptin B1 might be 
resistant to infection.
The diversity of the articles published in this special issue of 
MicrobiologyOpen supports that, as stated in the title, antibiotic 
resistance is a multifaceted problem that requires multipronged 
solutions.
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